Natural Bioactives as Potential Therapeutic Modalities Against NeuroAIDS

Author(s): Musheer Ahmed, Ashif Iqubal, Sanjula Baboota, Javed Ali*

Journal Name: Current Topics in Medicinal Chemistry

Volume 21 , Issue 12 , 2021

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


With the introduction of antiretroviral therapy, the worldwide AIDS-related deaths have decreased, and life expectancy has increased, including the prevalence of AIDS-related neurological disorders or neuroAIDS. HIV-associated neurocognitive disorders such as mild neurocognitive disorder and asymptomatic neurocognitive impairment have largely remained stable or increased among the HIV-infected individuals in the combination antiretroviral therapy era. The emerging evidence that antiretrovirals with high CNS penetration effectiveness score contribute to the neurotoxicity and HIV-associated neurocognitive disorders has ushered the search for natural, nontoxic bioactive constituents having pre-established neuroprotective, anti-inflammatory, and restorative neurocognitive activity. In this review, we have highlighted the probable mechanism of neuroAIDS infection, the problem with the existing antiretroviral therapy, along with various bioactive constituents with in vivo, in vitro, or ex vivo evidence of their neuroprotective activity that can be used as an adjuvant with the current combination antiretroviral therapy regimen or can even serve as an alternate to the antiretrovirals for treatment of HIV associated neurocognitive disorder.

Keywords: NeuroAIDS, HIV, Dementia, Antiretroviral therapy, Bioactive constituents, Neurocognitive disorders.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 12 April, 2021
Page: [1052 - 1066]
Pages: 15
DOI: 10.2174/1568026621666210412152428
Price: $65

Article Metrics

PDF: 124